News Center

Home page

Peak Report

News reports

All subordinate units of the group commend advanced

Release time:

2021-02-10

1# On May 25, at the 2020 work summary meeting held by Yunnan Jianfeng Cement Company, Zhou Jiping made a work report on behalf of Yunnan Jianfeng management team to summarize the production and operation situation in 2020. In 2020, Yunnan Peak overcame the impact of the epidemic and regional new capacity, in the difficult market environment, bucked the trend to create the highest sales in the eight years since the establishment of the plant, to achieve the only sales in southwest Yunnan over last year, the only receivables cleared of the same industry enterprises. Zhou Jiping objectively analyzed the problems and deficiencies in the work, and combined with the actual work in 2020, put forward suggestions on the business objectives, key work plans, work requirements and safeguard measures for 2021. Liu Shenghua, the new general manager of Yunnan Peak, has arranged the work for 2021 in combination with the actual production of Yunnan Peak. The

meeting commended the advanced collectives and individuals in 2020. Fang Xuhua, secretary of the Yunnan Jianfeng Party Branch, deputy general manager, and chairman of the labor union, hopes that all cadres and employees will take the advanced as an example and benchmark, find gaps based on their positions, everyone talks about performance than dedication, and is in line with the advanced, and in the face of new production and operation tasks, Strive to catch up and surpass head-on and reach a new high. At the summary and commendation meeting of the pharmaceutical company held on October 3, Huang Jinlong, deputy general manager of the group company and general manager of the pharmaceutical company, made an annual work report on behalf of the management team of the pharmaceutical company, he reviewed the main work in 2020 from the aspects of epidemic prevention and control and resumption of production, safety and environmental protection management, product development and technological innovation, marketing management, standardizing production and operation behavior, talent recruitment and training, brand promotion of companies and products, and the work of the party and government work group, and analyzed the industry policy and development trend in 2021. He pointed out that the pharmaceutical industry will still have to face strict industry regulatory policies and severe market competition in 2021, and "recovery, innovation, integration and compliance" will be the key words of China's pharmaceutical economy in 2021. The pharmaceutical company will focus on the overall goal of "reducing costs, expanding the market, increasing speed, and creating benefits", and carry out various production and operation management work in an orderly manner. Jiang Xiaomeng, chairman of

Group Company and chairman of Pharmaceutical Company, attended the meeting. On behalf of the Group Company, he congratulated the advanced collectives and individuals who were commended, affirmed the work of Jianfeng Pharmaceutical in 2020, and put forward requirements for the work of Pharmaceutical Company in 2021. He requested that pharmaceutical companies should create three advantages and create new performance from three aspects: innovative research and development, preparation costs, and API characteristics; make breakthroughs in innovative marketing, management capabilities and thinking, and further refresh marketing capabilities and labor productivity. Reduce costs. At the same time, he hopes that all employees of the pharmaceutical industry will have a sense of urgency, mission and crisis, and complete various indicators of the pharmaceutical company through the efforts of all parties. At the

meeting, the pharmaceutical company awarded the advanced collectives and individuals in 2020. On behalf of the pharmaceutical company, Huang Jinlong signed a new year's economic target responsibility system with the heads of its subordinate enterprises.

This meeting was presided over by Jin Huazhong, Secretary of the Party Committee of Pharmaceutical Company, and summarized the contents of the meeting.

On the 4th, Guizhou Huangping Jianfeng Cement Company held a summary commendation meeting to commend the advanced collectives and individuals in 2020 and convey the spirit of the group's annual business analysis meeting and summary commendation meeting. Huang Ping Jianfeng Manufacturing Department Yu Wang Yang, Purchasing Department Yang Changyuan and Marketing Department Long Liwei spoke at the meeting as advanced representatives.

On the 5th, at the summary commendation meeting held by daye peak cement company, Zhang Fengliang, deputy general manager of the group company and general manager of daye peak cement company, made a 2020 work report, summarizing the progress made by daye peak during the 13th Five-Year Plan period from the aspects of increasing per capita labor productivity year by year, continuous growth of employee income, increasingly standardized enterprise management, and effective technological transformation. He analyzed the challenges brought about by the changes in the external environment of the cement industry in 2021, as well as the shortcomings in the internal management of the enterprise, and required middle-level managers not only to learn from others and learn from others, but also to learn management knowledge and improve themselves. Management ability, always pay attention to the development of domestic and foreign industries, and know their own equipment and technical level; all employees should have a strong sense of responsibility and mission, have passion for work, transmit positive energy, do not care about it, base on their own work, earnestly safeguard the interests of the enterprise, work conscientiously, unite sincerely, and achieve the same progress and common development of enterprises and individuals. The

meeting also awarded honorary certificates to advanced individuals and collectives, and advanced representatives Ke Quanjun and Liu Lin made speeches.

2# On the afternoon of July 7, at the summary and commendation meeting of Jianfeng Health Technology Company, employees gathered together to sum up the past and talk about the future. The peak health management team presented awards to advanced collectives, outstanding employees and "1 1" direct purchase outstanding marketers. Yin Zhiwu, general manager of Jianfeng Health, said that in 2021, Jianfeng Health will focus on the business idea of developing health products (health food and ordinary food), supplemented by plant extracts and Chinese herbal pieces. It will make concerted efforts to create the fist products of health products business, focus on the investment promotion agency sector, and complement entrusted processing, group purchase and retail terminals. Organize production and operation in strict accordance with GMP requirements and food regulations; Strictly pay attention to safety and environmental protection work, strive to be a safe and environmentally friendly accident-free factory.

2 On the 8th, the cable company used the morning meeting platform to summarize and commend. Zhang Ci, general manager of the cable company, made an annual work report for 2020, summarizing the outstanding highlights and achievements of the marketing department, production department, technology department and comprehensive finance department, and arranging the specific work ideas and efforts for 2021. Yu Jianhong, general manager of

Group Company, attended the meeting and presented awards to advanced collectives and outstanding employees. He congratulated the advanced collectives and individuals, affirmed the achievements of the cable company in 2020, and put forward requirements for the work of the cable company in 2021. He hopes that all employees of the cable company will establish confidence and make persistent efforts to believe that they can cope with external difficulties and have the ability to enable the cable company to achieve better benefits; further strengthen management and improve the level of technology; further increase market acceptance capabilities and improve technology Level, expand customer coverage, and enhance the reputation of cable companies. (qi jianmei, ni yingzhen, pan yi, wang yuhua, xu ying, zhou guangliang, xu feng, huang yuan)

More information

Yunnan peak through the safety standard secondary acceptance

On March 21, Yunnan Jianfeng Cement Company successfully passed the evaluation and acceptance of secondary enterprises for safety production standardization. On the same day, a review team composed of leaders of the Yunnan Provincial Work Safety Supervision Bureau and relevant experts reviewed the implementation of the establishment of Yunnan Jianfeng safety production standardization secondary enterprises. According to the 13 elements involved in the "Standard for Assessment and Rating of Safety Production Standardization in Cement Enterprises", the review team conducted strict assessment and scoring item by item through grouping to check the site and review the data, and finally determined that Yunnan Peak passed the standard acceptance of safety standardization secondary enterprises. Yunnan Jianfeng has always attached great importance to safety production. After passing the three-level safety standard enterprise review in 2015, in order to raise the level of enterprise safety management to a new level, in 2016, it began to create secondary safety standardization. Over the past year, Yunnan Jianfeng has insisted on taking the creation of secondary safety standards as the top priority of production and operation management, and has formulated an implementation plan for production safety standardization in accordance with the requirements of national standardization norms. the content covers production safety responsibility system, education and training, safety inspection, safety facilities management and other safety production management standards, systems and post safety operation procedures, while further strengthening daily safety inspection and regularly organizing emergency plan drills, strengthen the investigation and rectification of potential safety hazards and the supervision of important hazard sources, and further consolidate the foundation of enterprise safety production management. After the review, Zhou Jiping, general manager of Yunnan Jianfeng, said that Yunnan Jianfeng will take this standard as a new starting point. On the basis of consolidating the accident-free achievements in production safety for two consecutive years, it will conscientiously implement the main responsibility of production safety and cultivate

2020

07-30

Pharmaceutical Company Invests in Beihui Bio-Peak Pharmaceutical Plate to Expand its Territory

News from our newspaper On February 28, the 10th meeting of the 9th Board of Directors of the Group Company reviewed and approved the "Proposal on Foreign Investment of Subsidiaries" and the "Proposal on Authorizing the Chairman of the Board of Directors." On the same day, Jianfeng Pharmaceutical signed the "Agreement on Capital Increase and Share Transfer of Beijing Huibaoyuan Biotechnology Co., Ltd." and the "Performance Commitment Compensation Agreement" with relevant parties. It is planned to use Beijing Huibaoyuan Biotechnology Co., Ltd. (Beihui Biotechnology) and its holding subsidiary Guangxi Huibaoyuan Pharmaceutical Technology Co., Ltd. (Guanghui Pharmaceutical) as a platform to jointly carry out new drug research and development, drug production and operation and other pharmaceutical business cooperation. Beihui Biological formerly known as Beijing Huibaoyuan Biotechnology Co., Ltd. The company has strong capabilities in new drug research and development. The actual controller is James Zhou (Zhou Hua), a returned entrepreneurial Ph.D. from Yale University in the United States, and hired Professor Zheng Yongqi from Yale University in the United States as the director of the Huibaoyuan Science and Technology Committee, focusing on anti-tumor and liver disease research. Through the cooperation with Yale University, we have obtained the patent authorization and commercial development license of the new anti-cancer chemical drug trasatabine (trokacitabine)(which has obtained the national new drug clinical approval in August 2016), the anti-hepatitis B chemical drug Crevudine (Clevudine). Guangxi Huibaoyuan Pharmaceutical Technology Co., Ltd., a subsidiary of Beihui Biology, is located in the third international park "China-Malaysia Qinzhou Industrial Park" jointly built by the Chinese government and foreign governments in Guangxi. It covers an area of 214.46 mu and has production workshops for multiple dosage forms such as percolation, tincture, solid preparations and liquid preparations.

2020

07-31

Peak health marketing and a new "play"

Building a New System, Flattening Management, Spike Health Marketing, New "Fit" On February 17, Spike Health Technology Company held a sales meeting to integrate and adjust the construction of a new marketing system and deploy and implement the 2017 sales work. Chen Daiyou, general manager of Health Technology Company, carefully explained and answered the marketing system construction and sales management assessment methods at the meeting, and reached a consensus on unifying thinking. The sales business of Health Technology Company involves three categories: health care products, plant extracts and Chinese herbal pieces. The product attributes and categories are different, and the product sales channels are diversified. In order to facilitate market expansion and adapt to the rapid response to market changes, the Company focuses on key products, key channels and key markets, adjusts the original division model, combines all sales businesses of the Company, establishes a marketing center, and centralizes and unifies flat management. At the meeting, the Health Technology Company issued the "2017 Sales Management Assessment Measures", which takes sales performance as the leading factor, defines the sales staff's business expenses and market expansion support policies, implements quarterly and annual assessment of sales targets, and directly links the assessment of the progress of sales staff's target tasks with monthly income. After two-way selection, adjustment and implementation of sales positions and target tasks, all sales staff of Health Technology Company have signed a sales economic responsibility system. Chen Daiyou hopes that marketers will build confidence to meet the challenges and grow and progress together with the enterprise. At the same time, he said that the health technology company will focus on strengthening the construction and cultivation of the sales team, and carry out training, learning and experience sharing in various ways, so as to improve the business ability and level of the sales team. (Spike Health)

2020

07-31

Peak health marketing and a new "play"

Building a New System, Flattening Management, Spike Health Marketing, New "Way to Work" On February 17, Spike Health Technology Company held a sales meeting to integrate and adjust the construction of a new marketing system and deploy and implement the 2017 sales work. Chen Daiyou, general manager of Health Technology Company, carefully explained and answered the marketing system construction and sales management assessment methods at the meeting, and reached a consensus on unifying thinking. The sales business of Health Technology Company involves three categories: health care products, plant extracts and Chinese herbal pieces. The product attributes and categories are different, and the product sales channels are diversified. In order to facilitate market expansion and adapt to the rapid response to market changes, the Company focuses on key products, key channels and key markets, adjusts the original business model, unifies all sales businesses of the Company, establishes a marketing center, and centralizes and unifies flat management. At the meeting, the Health Technology Company issued the "2017 Sales Management Assessment Measures", which takes sales performance as the leading factor, defines the sales staff's business expenses and market expansion support policies, implements quarterly and annual assessment of sales targets, and directly links the assessment of the progress of sales staff's target tasks with monthly income. After two-way selection, adjustment and implementation of sales positions and target tasks, all sales staff of Health Technology Company have signed a sales economic responsibility system. Chen Daiyou hopes that marketers will build confidence to meet the challenges and grow and progress together with the enterprise. At the same time, he said that the health technology company will focus on strengthening the construction and cultivation of the sales team, and carry out training, learning and experience sharing in various ways, so as to improve the business ability and level of the sales team. (Spike Health)

2020

07-31

Accident-free factory creation enters "second season"

At the beginning of the new year, a major "highlight" of the company's safety and environmental protection management in recent years-the "second quarter" of the establishment of a safety and environmental protection accident-free factory has also begun. Safety and environmental protection accident-free factory creation activities are an important measure for the company to improve the level of on-site management. The first phase of the activity will start on January 1, 2014 and end at the end of 2016 for a period of three years. Since the launch of the activity, all subordinate enterprises of the company have actively organized publicity and training related to safety and environmental protection, strengthened the awareness of safety and environmental protection of all employees, improved the management and operation level of safety and environmental protection; increased investment in safety and environmental protection facilities and equipment; strengthened safety and environmental protection inspection and self-examination and correction of hidden dangers, and timely organized rectification of hidden dangers; strictly assessed the units and relevant responsible persons of the accident, And the accident situation in the group, in order to arouse vigilance and avoid similar accidents. In the past three years, the company's subsidiaries have achieved remarkable results in standardization, safety, and clean operation. Safety and environmental protection accidents have dropped significantly, and no major accidents have occurred, which has effectively promoted the company's safe and civilized production construction. In the 2016 safety and environmental protection accident-free factory establishment assessment conducted a few days ago, a total of 6 units met the accident-free factory standard, of which Yunnan Jianfeng, Jianfeng International Trade and Pharmaceutical Department met the standard for the second consecutive year, and Daye Jianfeng, Qiubin Factory and Cable Company met the standard in the first year. In order to sum up experience and further improve the level of safety and environmental protection management, the Group decided to continue to open

2020

07-31

What will the Chinese Medicine Act bring us?

At the 25th meeting of the Standing Committee of the 12th National People's Congress in December 2016, the the People's Republic of China Chinese Medicine Law (hereinafter referred to as the Chinese Medicine Law) was deliberated and passed, which will come into effect on July 1 this year. As the first comprehensive law that comprehensively and systematically embodies the characteristics of traditional Chinese medicine, the Law of traditional Chinese Medicine clearly stipulates the service of traditional Chinese medicine, the protection and development of traditional Chinese medicine, the training of talents of traditional Chinese medicine, and the scientific research of traditional Chinese medicine. With the change of people's health concept and the continuous innovation of medical mode in recent years, the role of traditional Chinese medicine in health is becoming more and more important. The promulgation of the "Traditional Chinese Medicine Law" has made the development of Chinese medicine more law-based, and it is bound to bring changes to domestic pharmaceutical companies. So, the peak of the pharmaceutical, health products companies will look at the "Chinese Medicine Law", and will have how to deal with it? A few days ago, the reporter interviewed the pharmaceutical companies and peak health technology companies related to the person in charge. What will the Chinese Medicine Act bring us? Reporter: As the general manager of Peak Pharmaceutical, what do you think of the Chinese Medicine Law? Huang Jinlong (Deputy General Manager of the Group Company and General Manager of the Pharmaceutical Company): the Law of traditional Chinese Medicine defines the important position and development policy of traditional Chinese medicine. The state encourages traditional Chinese medicine and western medicine to learn from each other, complement each other, coordinate development, give full play to their respective advantages, and promote the integration of traditional Chinese and western medicine. Traditional Chinese medicine is a huge knowledge system, reflecting the Chinese nation's understanding of life, health and disease. It is precisely because of the distinctive characteristics of Chinese medicine that the Law of Chinese Medicine is used in Chinese medicine clinics, Chinese medicine physicians and doctors.

2020

07-31

< 1...49 50 51...61 > 跳转到页